Manufacturer
L.B.S. LABS LTD PART
Contents
Terbutaline sulphate
Indication
Uncomplicated premature labour, Severe bronchospasm
Instruction
Administer via SC/IM, IV Injection or by IV Infusion
Drug interaction
Increased risk of haemorrhage and serious ventricular rhythm disorder w/ halogenated anaesth. May reduce the effect of anti-diabetic drugs. Increased risk of hypokalaemia w/ K-depleting agents (e.g. diuretics). Concomitant β-agonist and corticosteroid may result to pulmonary oedema. May partially or totally inhibit the effect of non-selective β-blockers.
L.B.S. LABS LTD PART
Contents
Terbutaline sulphate
Indication
Uncomplicated premature labour, Severe bronchospasm
Instruction
Administer via SC/IM, IV Injection or by IV Infusion
Drug interaction
Increased risk of haemorrhage and serious ventricular rhythm disorder w/ halogenated anaesth. May reduce the effect of anti-diabetic drugs. Increased risk of hypokalaemia w/ K-depleting agents (e.g. diuretics). Concomitant β-agonist and corticosteroid may result to pulmonary oedema. May partially or totally inhibit the effect of non-selective β-blockers.
Inquiry - Baltic Injection 0.5mg/ml